Defence Therapeutics Inc.

DTCFF · OTC
Analyze with AI
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Assets
Cash & Equivalents$57$2,793$507$5,453
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$61$492$139$39
Total Curr. Assets$214$3,435$674$5,563
Property Plant & Equip (Net)$264$59$0$0
Goodwill$0$0$0$0
Intangibles$0$39$46$46
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$264$98$46$46
Other Assets$0$0$0$0
Total Assets$478$3,533$720$5,609
Liabilities
Payables$2,091$192$1$0
Short-Term Debt$1,739$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$225$29$1,106$122
Total Curr. Liab.$4,054$220$1,107$122
LT Debt$8$1,746$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$8$1,746$0$0
Other Liabilities$0$0$0$0
Cap. Leases$36$0$0$0
Total Liabilities$4,062$1,967$1,107$122
Equity
Pref Stock$0$0$0$0
Common Stock$19,242$16,951$9,334$7,971
Retained Earnings-$29,808-$16,907-$10,516-$3,533
AOCI$0$1,522$794$1,048
Other Equity$6,981$0$0$0
Total Equity-$3,584$1,566-$388$5,487
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$478$3,533$720$5,609
Net Debt$1,690-$1,047-$507-$5,453